An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).
University of Queensland researcher Dr Christian Gruber said the breakthrough could be a step forward in preventing and treating MS and other autoimmune diseases.
“This is a really exciting discovery because it may offer a whole new quality of life for people with this debilitating disease,” he said.
The new drug is expected to be taken by mouth, in contrast to some current MS treatments where patients need to have frequent injections.
MS is a chronic incurable condition marked by attacks that bring gradual deterioration in the patient’s health. About 23,000 people are affected in Australia and 2.5 million worldwide.
Dr Gruber said the new drug – named T20K – was extracted from a traditional medicinal plant, the Oldenlandia affinis.
The drug treatment had been successful in an animal model, and patent applications filed in several countries.
“Phase one clinical trials could begin as early as 2018,” Dr Gruber said.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases.
“Cyxone’s immediate focus is on bringing T20K through the pre-clinical program required for delivering a safe, orally active drug.”
Dr Gruber said the new treatment arose from a synthesised plant peptide, a class of drugs known as cyclotides.
“Cyclotides are present in a range of common plants, and they show significant potential for the treatment of auto immune diseases,” he said.
“The T20K peptides exhibit extraordinary stability and chemical features that are ideally what you want in an oral drug candidate.”
The international research team demonstrated in an animal model that T20K stopped progression in the normal clinical symptoms of MS.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- Being bilingual may help protect cognitive decline in multiple sclerosis patientson January 16, 2020 at 6:57 am
Bilingual speakers may benefit from protection against cognitive decline in multiple sclerosis according to a new study. In the first paper of its kind to test the idea that speaking multiple ...
- Costs for multiple sclerosis meds tripled in past decadeon January 16, 2020 at 12:15 am
The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows. The 2015 release of glatiramer acetate -- ...
- Dorothy Schafer lab shows gene therapy protection of eyesight in models of multiple sclerosison January 14, 2020 at 12:34 pm
New research by Dorothy P. Schafer, PhD, reveals the molecular process in which synaptic connections in the brain are damaged in multiple sclerosis and how this contributes to neurodegenerative ...
- Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028on January 14, 2020 at 8:10 am
/PRNewswire/ -- Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 Summary Read the full ...
- MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson's Diseaseon January 14, 2020 at 4:00 am
/PRNewswire/ -- MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software, and music to measure and improve walking, ...
- Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosison January 14, 2020 at 2:18 am
Here, using single cell transcriptomics, we identify a specific location-associated composition and transcriptome of CSF leukocytes. Multiple sclerosis (MS) – an autoimmune disease of the CNS – ...
- Transcript specific regulation of expression influences susceptibility to multiple sclerosison January 13, 2020 at 9:55 am
All prices are NET prices. VAT will be added later in the checkout. IMSGC and WTCCC2 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214–9.
- Robotic exoskeleton helps woman with multiple sclerosis walkon January 13, 2020 at 9:48 am
Kathy Miska, 56, of Strongsville, Ohio is fighting multiple sclerosis one step at a time. Multiple sclerosis, or MS, disrupts signals from the brain and often robs people of their mobility. Miska is ...
- High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’on January 13, 2020 at 5:54 am
The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” and alter their use of the medicines, such as cutting back or skipping dosages altogether. And many ...
- Work Out, Don’t Burn Out, With Multiple Sclerosison January 9, 2020 at 9:57 pm
As the winter holidays approached this past year, along with the food and fun that typically come with them, I found myself bombarded with questions like these: If I cheat on my diet, will that cause ...
via Bing News